For: | Yang WN, Pang LL, Zhou JY, Qiu YW, Miao L, Wang SY, Liu XZ, Tan KA, Shi WW, Wang GQ, Hou FQ. Single-nucleotide polymorphisms of HLA and Polygonum multiflorum-induced liver injury in the Han Chinese population. World J Gastroenterol 2020; 26(12): 1329-1339 [PMID: 32256020 DOI: 10.3748/wjg.v26.i12.1329] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i12/1329.htm |
Number | Citing Articles |
1 |
Can Tu, Ming Niu, Ai-Wu Wei, Jin-Fa Tang, Le Zhang, Jing Jing, Xiao-He Xiao, Jia-Bo Wang. Susceptibility-Related Cytokine Panel for Prediction of Polygonum multiflorum-Induced Hepatotoxicity in Humans. Journal of Inflammation Research 2021; : 645 doi: 10.2147/JIR.S299892
|
2 |
Le Zhang, Ming Niu, Ai-wu Wei, Jin-fa Tang, Peng-yan Li, Di Song, Zhao-fang Bai, You-ping Liu, Xiao-he Xiao, Jia-bo Wang. Clinical correlation between serum cytokines and the susceptibility to Polygonum multiflorum-induced liver injury and an experimental study. Food & Function 2022; 13(2): 825 doi: 10.1039/D1FO03489H
|
3 |
Andrew Stolz. Newly identified genetic variants associated with idiosyncratic drug-induced liver injury. Current Opinion in Gastroenterology 2022; 38(3): 230 doi: 10.1097/MOG.0000000000000822
|
4 |
Camilla Stephens, M Isabel Lucena, Raúl J Andrade. Genetic risk factors in the development of idiosyncratic drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 2021; 17(2): 153 doi: 10.1080/17425255.2021.1854726
|
5 |
Tekleab Teka, Liming Wang, Jian Gao, Jiajia Mou, Guixiang Pan, Haiyang Yu, Xiumei Gao, Lifeng Han. Polygonum multiflorum: Recent updates on newly isolated compounds, potential hepatotoxic compounds and their mechanisms. Journal of Ethnopharmacology 2021; 271: 113864 doi: 10.1016/j.jep.2021.113864
|
6 |
I. A. Mazerkina. Idiosyncratic Drug-Induced Liver Injury: From Pathogenesis to Risk Reduction. Safety and Risk of Pharmacotherapy 2023; 11(2): 204 doi: 10.30895/2312-7821-2023-11-2-204-214
|
7 |
Helgi Kristinn Björnsson, Einar Stefan Björnsson. Review of human risk factors for idiosyncratic drug-induced liver injury: latest advances and future goals. Expert Opinion on Drug Metabolism & Toxicology 2023; 19(12): 969 doi: 10.1080/17425255.2023.2288260
|
8 |
Association of HLA-B Gene Polymorphisms with Type 2 Diabetes in Pashtun Ethnic Population of Khyber Pakhtunkhwa, Pakistan. Journal of Diabetes Research 2021; 2021: 1 doi: 10.1155/2021/6669731
|
9 |
Zhi-Tao Ma, Zhuo Shi, Xiao-He Xiao, Jia-Bo Wang. New Insights into Herb-Induced Liver Injury. Antioxidants & Redox Signaling 2023; 38(16-18): 1138 doi: 10.1089/ars.2022.0134
|
10 |
Chen-Xi Yang, Dong-Mei Yao. Research advances in pathogenesis and diagnostic markers of drug-induced liver injury. World Chinese Journal of Digestology 2021; 29(13): 726 doi: 10.11569/wcjd.v29.i13.726
|
11 |
Yujie Wang, Wen Xie. Drug-induced liver injury: An overview and update. Gastroenterology & Endoscopy 2023; 1(2): 102 doi: 10.1016/j.gande.2022.11.005
|
12 |
Stephanie M Woo, William D Davis, Soorya Aggarwal, Joseph W Clinton, Sara Kiparizoska, James H Lewis. Herbal and dietary supplement induced liver injury: Highlights from the recent literature. World Journal of Hepatology 2021; 13(9): 1019-1041 doi: 10.4254/wjh.v13.i9.1019
|
13 |
Kangan Tan, Wanna Yang, Lili Pang, Fengqin Hou. Differences in clinical characteristics among 726 patients with Chinese herbal medicine- or Western medicine-induced liver injury. Medicine 2022; 101(32): e29909 doi: 10.1097/MD.0000000000029909
|
14 |
Wenhui Liu, Xiangchang Zeng, Xinfeng Wang, Yuwei Hu, Lulu Chen, Naixiang Luo, Dongsheng Ouyang, Tai Rao. 2,3,5,4′- tetrahydroxystilbene-2-O-β-D- glucopyranoside (TSG)-Driven immune response in the hepatotoxicity of Polygonum multiflorum. Journal of Ethnopharmacology 2024; 326: 117865 doi: 10.1016/j.jep.2024.117865
|
15 |
Xing-Ran Zhai, Zheng-Sheng Zou, Jia-Bo Wang, Xiao-He Xiao. Herb-Induced Liver Injury Related to Reynoutria multiflora (Thunb.) Moldenke: Risk Factors, Molecular and Mechanistic Specifics. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.738577
|